A detailed history of Citigroup Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Citigroup Inc holds 1,359,154 shares of NVO stock, worth $117 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,359,154
Previous 1,330,447 2.16%
Holding current value
$117 Million
Previous $190 Million 14.78%
% of portfolio
0.1%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $3.42 Million - $4.17 Million
28,707 Added 2.16%
1,359,154 $162 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $2.72 Million - $3.26 Million
22,164 Added 1.69%
1,330,447 $190 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $74.7 Million - $99.4 Million
731,539 Added 126.84%
1,308,283 $168 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $480,595 - $577,338
5,475 Added 0.96%
576,744 $59.7 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $28.2 Million - $61.9 Million
310,026 Added 118.67%
571,269 $52 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $594,127 - $657,623
3,809 Added 1.48%
261,243 $42.3 Million
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $708,283 - $851,717
5,352 Added 2.12%
257,434 $41 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $3.6 Million - $4.75 Million
35,074 Added 16.16%
252,082 $34.1 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $96,899 - $118,917
-1,017 Reduced 0.47%
217,008 $21.6 Million
Q2 2022

Aug 10, 2022

BUY
$103.24 - $121.81 $5.77 Million - $6.8 Million
55,851 Added 34.44%
218,025 $24.3 Million
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $1.4 Million - $1.69 Million
15,040 Added 10.22%
162,174 $18 Million
Q4 2021

Feb 10, 2022

BUY
$95.88 - $117.08 $2.97 Million - $3.63 Million
30,980 Added 26.67%
147,134 $16.5 Million
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $9.81 Million - $12.4 Million
116,154 New
116,154 $11.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.